Immunosuppression affects the severity of experimental Fusarium solani keratitis

Tzu G Wu1, Victor V Keasler, Bradley M Mitchell

  • 1Sid W. Richardson Ocular Microbiology Laboratory, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas 77030, USA.

Insights

This study establishes a mouse model for corneal fusariosis, demonstrating that immunosuppression enhances Fusarium solani keratitis development and progression, aiding infection evaluation.

Area of Science:

  • Ophthalmology
  • Mycology
  • Immunology

Background:

  • Corneal fusariosis is a severe fungal keratitis.
  • Current models for studying Fusarium solani keratitis are limited.
  • Understanding fungal pathogenesis is crucial for treatment.

Purpose of the Study:

  • To establish and validate a mouse model for corneal fusariosis.
  • To evaluate the role of immunosuppression in Fusarium solani keratitis.
  • To enable in vivo and in vitro assessment of fungal keratitis.

Main Methods:

  • BALB/c mice (immunocompetent and cyclophosphamide-treated) were inoculated with Fusarium solani after corneal scarification.
  • Ocular scoring for disease severity was performed daily for 8 days and at 2 weeks.
  • Fungal load was quantified via microbial culturing, and histopathology was conducted on corneal tissues.

Main Results:

  • A dose-response relationship was observed in cyclophosphamide-treated mice.
  • Cyclophosphamide treatment increased disease severity and delayed fungal clearance.
  • Histopathology revealed fungal hyphae, inflammatory cells, and stromal edema correlating with disease severity.

Conclusions:

  • A mouse model for corneal fusariosis was successfully established.
  • Immunosuppression facilitates the induction and progression of Fusarium solani keratitis.
  • This model allows for comprehensive evaluation of fungal keratitis in vivo and in vitro.